Talking Life Sciences

Episode 18 - Regulatory and Policy Developments from South Africa – SAHPRA’s Proposed Black Economic Empowerment (BEE) Policy

In this episode of Covington’s Life Sciences Podcast [https://www.cov.com/en/topics/talking-life-sciences-audiocast], Mosa Mkhize [https://www.cov.com/en/professionals/m/mosa-mkhize] and Deon Govender [https://www.cov.com/en/professionals/g/deon-govender] discuss Regulatory and policy developments from South Africa: SAHPRA’s proposed Black Economic Empowerment (BEE) policy and its potential impact on license holders for medicines and medical devices

Episode 17 - Developments in the African Medicines Agency and Regulatory Convergence

In this episode of Covington’s Life Sciences Podcast [https://www.cov.com/en/topics/talking-life-sciences-audiocast], Mosa Mkhize [https://www.cov.com/en/professionals/m/mosa-mkhize] and Grant Castle [https://www.cov.com/en/professionals/c/grant-castle] discuss developments in the African Medicines Agency and regulatory convergence.

Episode 16 - WHO Prequalification Procedures in Africa

In this episode of Covington’s Life Sciences Podcast [https://www.cov.com/en/topics/talking-life-sciences-audiocast], Mosa Mkhize [https://www.cov.com/en/professionals/m/mosa-mkhize] and Roderick Dirkzwager [https://www.cov.com/en/professionals/d/roderick-dirkzwager] discuss WHO prequalification procedures in Africa.

Episode 15 - Green Claims – Recent Developments in EU Regulation and Enforcement

In this episode of Covington’s Life Sciences Podcast [https://www.cov.com/en/topics/talking-life-sciences-audiocast], Seán Finan [https://www.cov.com/en/professionals/f/sean-finan] discuss some important recent developments in the regulation of sustainability and green claims and labelling schemes, and the ever-increasing enforcement risk that comes with greenwashing.

Episode 14 - EU Pharma Law Review – Focus on Incentives

In this episode of Covington’s Life Sciences Podcast [https://www.cov.com/en/topics/talking-life-sciences-audiocast], Marie Doyle-Rossi [https://www.cov.com/en/professionals/d/marie-doyle-rossi], Anna Wawrzyniak [https://www.cov.com/en/professionals/w/anna-wawrzyniak], and Valeria Sturla [https://www.cov.com/en/professionals/s/valeria-sturla] discuss the position adopted by the European Parliament on 10 April 2024 on the Commission proposal to reform the core EU pharmaceutical legislation. Parliament’s position comes less than a year since the Commission published its proposal, and constitutes a significant step in the legislative process. Although many of the Parliament’s amendments to the Commission proposal can be seen as improvements by the innovative industry, many challenges and some unresolved questions remain, especially in relation to the incentive regime. During this audiocast, we therefore discuss improvements, challenges and unresolved questions of the EU Pharma law review, with a particular focus on incentives.